Berlin, August 27th, 2020. The Berlin-based health platform Heartbeat Labs won Christoph Oldenburg as a new Managing Director from September 2020 on. Oldenburg is a qualified biochemist and has worked at the business consultancy Catenion in the area of R&D strategy in the pharmaceutical industry since 2014, recently as a Principal. He will complement the existing management team with his wide experience in identifying market potentials and in implementing new business models in the field of biotechnology and in the pharmaceutical market.
“Heartbeat Labs drives entrepreneurial innovation in the healthcare market together with established players”, says Dr. Johannes Keienburg, Managing Director of Heartbeat Labs. “We applied this model already successfully in many areas and are looking forward to extending our focus onto the pharmaceutical industry together with Christoph. Given his background, he is an ideal addition to our team.”
“New digital and biotechnological possibilities are fundamentally changing the way we think about and understand healthcare in the future”, says Christoph Oldenburg. “The Heartbeat Labs team has a portfolio with a strong track record of technology-based, patient-oriented business models. I am looking forward to contributing my experience to their knowledge, and this increasingly in the areas of biotech and the pharmaceutical market.”
Since 2017, Heartbeat Labs has founded five startups and invested in nine companies through their platform. Out of the total portfolio, three companies have successfully been exited. Since 2019, Heartbeat Labs is an anchor investor and expert partner at Heal Capital, the leading European VC fund focusing on technology enabled-healthcare champions.